A/P 12.5/15 (Alogliptin Benzoate and Pioglitazone Hydrochloride 12.5 mg / 15 mg)
Pill with imprint A/P 12.5/15 is Yellow, Round and has been identified as Alogliptin Benzoate and Pioglitazone Hydrochloride 12.5 mg / 15 mg. It is supplied by Perrigo New York Inc.
Alogliptin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Alogliptin/pioglitazone 12.5 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A/P 12.5/15
Alogliptin Benzoate and Pioglitazone Hydrochloride
- Imprint
- A/P 12.5/15
- Strength
- 12.5 mg / 15 mg
- Color
- Yellow
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Perrigo New York Inc.
- National Drug Code (NDC)
- 45802-0238
- Inactive Ingredients
-
mannitol,
microcrystalline cellulose,
croscarmellose sodium,
magnesium stearate,
hypromellose 2910 (6 mPa.s),
titanium dioxide,
polyethylene glycol 8000,
magnesium silicate,
lactose monohydrate,
ferric oxide yellow,
ferric oxide red,
carnauba wax,
polyglyceryl-10 oleate,
butyl alcohol,
alcohol,
shellac
Note: Inactive ingredients may vary.
Related images for "A/P 12.5/15"
More about alogliptin / pioglitazone
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (2)
- Drug images
- Pricing & coupons
- En español
- Drug class: antidiabetic combinations
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.